<DOC>
	<DOC>NCT01467635</DOC>
	<brief_summary>A prospective diagnostic clinical study randomising patients undergoing endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) of enlarged mediastinal and hilar lymph nodes to have sampling using the usual EBUS-TBNA needle or a novel biopsy forceps (EBUS-TBNB). The study aims to establish whether the use of EBUS-TBNB can significantly increase the diagnostic yield over EBUS-TBNA, without an increase in complication rates.</brief_summary>
	<brief_title>EBUS-TBNA Versus EBUS-TBNB</brief_title>
	<detailed_description />
	<mesh_term>Sarcoidosis</mesh_term>
	<mesh_term>Mycobacterium Infections</mesh_term>
	<criteria>Scheduled for EBUSTBNA as part of clinical care Lymph nodes larger than 10mm in diameter Age &gt; 18 years Able to provide written informed consent Contraindications for needle or forceps biopsy (e.g. coagulopathy, anticoagulation, thrombocytopenia) Inability to obtain informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Endobronchial ultrasound</keyword>
	<keyword>Transbronchial needle aspiration</keyword>
	<keyword>Transbronchial biopsy forceps</keyword>
	<keyword>Mediastinal lymphadenopathy</keyword>
	<keyword>Hilar lymphadenopathy</keyword>
</DOC>